🇦🇪 UAE Stock Available — 2 Hour Delivery Dubai  ·  Research Use Only  ·  COA Included with Every Batch
Triple Agonist Research Compound

Retatrutide
Pen

30mg · Prefilled FlexiPen

The most advanced metabolic research compound in its class. Simultaneous GLP-1, GIP, and glucagon receptor activation in a precision-dosing, pH-balanced, ready-to-use format. No reconstitution required.

Retatrutide Pen 30mg — Remedium Research
Retatrutide Pen 30mg
Remedium Research
Retatrutide Pen
30mg · Stabilised Solution · pH Balanced
Purity
≥99%
Format
FlexiPen
Per Click
0.5mg
Storage
2–8°C
AED 999
/ pen
Free UAE delivery on orders over AED 1,500
In Stock — UAE · 2 Hour Delivery Dubai
⚗️
≥99% PurityHPLC Verified · COA Included
🇦🇪
UAE Stock2 Hour Delivery Dubai
🧊
Cold-ChainTemperature Controlled
🔬
Research OnlyFor Qualified Professionals
The Mechanism

Three receptors.
One compound.

01 —
Glucagon-Like Peptide
GLP-1 Receptor
Stimulates insulin secretion, suppresses appetite signalling, and slows gastric emptying. The same pathway targeted by Semaglutide and Liraglutide — but here, one of three simultaneous activations.
02 —
Glucose-Dependent Insulinotropic
GIP Receptor
Works synergistically with GLP-1 to enhance insulin response and shows emerging evidence of direct effects on adipose tissue. Also targeted by Tirzepatide in the dual-agonist class.
03 —
Glucagon Receptor
GCGR Receptor
The differentiator. Co-activation at the glucagon receptor appears to increase energy expenditure, raising metabolic rate — a mechanism unique to the triple-agonist class and absent from all approved GLP-1 therapies.
24%
Mean Body Weight
Reduction — Phase 2
(48 Weeks)
Receptor Pathways
Simultaneously
Activated
Ph.3
Current Trial
Status — Eli Lilly
LY3437943
  • Format Prefilled FlexiPen
  • Total Volume 30mg Retatrutide
  • Solution Stabilised · pH Balanced
  • Administration Subcutaneous · Research
  • Needle Gauge 31G · 5mm
  • Storage 2–8°C
  • Purity ≥99% HPLC Verified
Box Contents
  • 1× Prefilled FlexiPen (30mg Retatrutide)
  • 20× Pen Needles (5mm 31G)
  • 1× Instruction Leaflet
  • Certificate of Analysis (COA)

Click-controlled.
No measuring.

Unlike lyophilised powder formats requiring reconstitution, the Retatrutide Pen eliminates preparation variables entirely. The stabilised solution is pre-mixed, pH-balanced, and ready for research application from the moment it arrives.

Each click of the FlexiPen mechanism delivers a precise 0.5mg dose — allowing researchers to administer consistent, repeatable quantities across study protocols without weighing, mixing, or measuring.

Click Reference Guide
1 Click 0.5mg minimum single dose
5 Clicks 2.5mg minimum advisable study dose
60 Clicks 30mg maximum single (full pen)
Total Doses 60 doses at 1-click increments
Place Your Order

UAE Stock.
2 Hour Delivery Dubai.

All orders fulfilled from UAE stock. 2 hour delivery across Dubai.
For laboratory research use only. By ordering you confirm you are a qualified research professional aged 21+.

1 Pen
AED 999
per pen
3 Pens
AED 2,697
AED 899 per pen
Save AED 300
5 Pens
AED 4,245
AED 849 per pen
Save AED 750
Payment Method
🏦Bank Transfer
Crypto (USDT)
FOR RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. All products are intended exclusively for in-vitro laboratory research and scientific investigation by qualified professionals. By placing an order you confirm you are aged 21 or older and a qualified research professional. Purchasers assume full responsibility for compliance with applicable local regulations. Remedium Research / ProPeptide does not endorse off-label use.
Certificate of Analysis

Third-Party Tested.
Verified Purity.

Every batch is independently tested by Janoshik Analytical — a leading third-party laboratory specialising in pharmaceutical purity analysis. Full test reports are included with every order.

Certificate of Analysis — Janoshik Test Report for Retatrutide 30mg by Remedium Research
Laboratory
Janoshik Analytical
Batch
RETP002
Purity
99.262%
Date Tested
04 Nov 2025